Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study

Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study

Background: Pancreatic cancer is the most common pancreatic solid malignancy with an aggressive clinical course and low survival rate. There are a limited number of reliable prognostic biomarkers and a need to understand the pathogenesis of pancreatic tumors; neuroendocrine (PNET) and pancreatic duc...

Full description

Bibliographic Details
Main Authors: Karolina Skubisz, Krzysztof Dąbkowski, Emilia Samborowska, Teresa Starzyńska, Anna Deskur, Filip Ambrozkiewicz, Jakub Karczmarski, Mariusz Radkiewicz, Katarzyna Kusnierz, Beata Kos-Kudła, Tadeusz Sulikowski, Patrycja Cybula, Agnieszka Paziewska
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
pancreatic ductal adenocarcinoma (PDAC)
neuroendocrine pancreatic tumor (PNET)
pancreas
pancreatic tumor
metabolite
metabolome
Online Access:https://www.mdpi.com/2072-6694/15/12/3242

Internet

https://www.mdpi.com/2072-6694/15/12/3242

Similar Items